Elka Touitou

Prof. Elka Touitou

The Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2000 in Journal of Controlled Release
Verified
Journal Article
Closed access
Elka TouitouElka Touitou
Elka Touitou
NDN Dayan
N Dayan
LBL Bergelson
L Bergelson
BGB Godin
B Godin
MEM Eliaz
M Eliaz

1 November 2001 in Biomaterials
Verified
Journal Article
Closed access
Elka TouitouElka Touitou
Elka Touitou
BGB Godin
B Godin
NDN Dayan
N Dayan
CWC Weiss
C Weiss
APA Piliponsky
A Piliponsky
FLFrancesca Levi-Schaffer
Francesca Levi-Schaffer

1 July 2000 in Drug Development Research
Verified
Journal Article
Closed access
PDF file
Elka TouitouElka Touitou
Elka Touitou
Biana GodinBiana Godin
Biana Godin
CWCeleste Weiss
Celeste Weiss

27 June 2020 in Molecules
Verified
Journal Article
Open access
PDF file
HNHiba Natsheh
Hiba Natsheh
Elka TouitouElka Touitou
Elka Touitou
This is a comprehensive review on the use of phospholipid nanovesicles for dermal/transdermal and nasal drug administration. Phospholipid-based vesicular carriers have been widely investigated for enhanced drug delivery via dermal/transdermal routes. Classic phospholipid vesicles, liposomes, do not penetrate the deep layers of the skin, but remain confined to the upper stratum corneum. The literature describes several approaches with the aim of altering the properties of these vesicles to improve their penetration properties. Transfersomes and ethosomes are the most investigated penetration-enhancing phospholipid nanovesicles, obtained by the incorporation of surfactant edge activators and high concentrations of ethanol, respectively. These two types of vesicles differ in terms of their structure, characteristics, mechanism of action and mode of application on the skin. Edge activators contribute to the deformability and elasticity of transfersomes, enabling them to penetrate through pores much smaller than their own size. The ethanol high concentration in ethosomes generates a soft vesicle by fluidizing the phospholipid bilayers, allowing the vesicle to penetrate deeper into the skin. Glycerosomes and transethosomes, phospholipid vesicles containing glycerol or a mixture of ethanol and edge activators, respectively, are also covered. This review discusses the effects of edge activators, ethanol and glycerol on the phospholipid vesicle, emphasizing the differences between a soft and an elastic nanovesicle, and presents their different preparation methods. To date, these differences have not been comparatively discussed. The review presents a large number of active molecules incorporated in these carriers and investigated in vitro, in vivo or in clinical human tests.

1 December 1998 in Journal of Controlled Release
Verified
Journal Article
Closed access
Elka TouitouElka Touitou
Elka Touitou
VMVictor M Meidan
Victor M Meidan
EHEhud Horwitz
Ehud Horwitz

18 March 2021 in Colloids and Interfaces
Verified
Journal Article
Open access
PDF file
AZAmani Zoabi
Amani Zoabi
Elka TouitouElka Touitou
Elka Touitou
KMKaty Margulis
Katy Margulis
The stratum corneum, the most superficial layer of the skin, protects the body against environmental hazards and presents a highly selective barrier for the passage of drugs and cosmetic products deeper into the skin and across the skin. Nanomaterials can effectively increase the permeation of active molecules across the stratum corneum and enable their penetration into deeper skin layers, often by interacting with the skin and creating the distinct sites with elevated local concentration, acting as reservoirs. The flux of the molecules from these reservoirs can be either limited to the underlying skin layers (for topical drug and cosmeceutical delivery) or extended across all the sublayers of the epidermis to the blood vessels of the dermis (for transdermal delivery). The type of the nanocarrier and the physicochemical nature of the active substance are among the factors that determine the final skin permeation pattern and the stability of the penetrant in the cutaneous environment. The most widely employed types of nanomaterials for dermal and transdermal applications include solid lipid nanoparticles, nanovesicular carriers, microemulsions, nanoemulsions, and polymeric nanoparticles. The recent advances in the area of nanomaterial-assisted dermal and transdermal delivery are highlighted in this review.